A new targeted therapy class for menopause-related hot flashes FDA greenlights Bayer’s first-in-class drug and non-hormonal option in the vasomotor-symptom space.

https://www.drugdiscoverynews.com/a-new-targeted-therapy-class-for-menopause-related-hot-flashes-16773